Maass N - Search Results

1

Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancer.

Maass N, Schem C, Bauerschlag DO, Tiemann K, Schaefer FW, Hanson S, Muth M, Baier M, Weigel MT, Wenners AS, Alkatout I, Bauer M, Jonat W, Mundhenke C. Maass N, et al. Oncology. 2014;87(5):300-10. doi: 10.1159/000365553. Epub 2014 Aug 26. Oncology. 2014. PMID: 25171229 Clinical Trial.

2

Sexual activity as cause for non-surgical pneumoperitoneum.

Jacobs VR, Mundhenke C, Maass N, Hilpert F, Jonat W. Jacobs VR, et al. Among authors: maass n. JSLS. 2000 Oct-Dec;4(4):297-300. JSLS. 2000. PMID: 11051188 Free PMC article.

3

Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.

Maass N, Hojo T, Zhang M, Sager R, Jonat W, Nagasaki K. Maass N, et al. Acta Oncol. 2000;39(8):931-4. doi: 10.1080/02841860050215909. Acta Oncol. 2000. PMID: 11206999 Review.

4

Expression of the tumor suppressor gene Maspin in human pancreatic cancers.

Maass N, Hojo T, Ueding M, Lüttges J, Klöppel G, Jonat W, Nagasaki K. Maass N, et al. Clin Cancer Res. 2001 Apr;7(4):812-7. Clin Cancer Res. 2001. PMID: 11309327

5

Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis.

Maass N, Hojo T, Rösel F, Ikeda T, Jonat W, Nagasaki K. Maass N, et al. Clin Biochem. 2001 Jun;34(4):303-7. doi: 10.1016/s0009-9120(01)00220-x. Clin Biochem. 2001. PMID: 11440731

6

Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast.

Maass N, Teffner M, Rösel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P. Maass N, et al. J Pathol. 2001 Oct;195(3):321-6. doi: 10.1002/path.948. J Pathol. 2001. PMID: 11673829

7

Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer.

Maass N, Rösel F, Schem C, Hitomi J, Jonat W, Nagasaki K. Maass N, et al. Cancer Lett. 2002 Nov 28;185(2):219-23. doi: 10.1016/s0304-3835(02)00286-0. Cancer Lett. 2002. PMID: 12169396

8

Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer.

Maass N, Biallek M, Rösel F, Schem C, Ohike N, Zhang M, Jonat W, Nagasaki K. Maass N, et al. Biochem Biophys Res Commun. 2002 Sep 13;297(1):125-8. doi: 10.1016/s0006-291x(02)02136-8. Biochem Biophys Res Commun. 2002. PMID: 12220518

9

Expression and regulation of tumor suppressor gene maspin in breast cancer.

Maass N, Nagasaki K, Ziebart M, Mundhenke C, Jonat W. Maass N, et al. Clin Breast Cancer. 2002 Oct;3(4):281-7. doi: 10.3816/CBC.2002.n.032. Clin Breast Cancer. 2002. PMID: 12425757

10

Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis.

Nagasaki K, Schem C, von Kaisenberg C, Biallek M, Rösel F, Jonat W, Maass N. Nagasaki K, et al. Among authors: maass n. Int J Cancer. 2003 Jul 1;105(4):454-8. doi: 10.1002/ijc.11122. Int J Cancer. 2003. PMID: 12712434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters